InvestorsHub Logo
Followers 22
Posts 1558
Boards Moderated 0
Alias Born 01/23/2014

Re: dhbuzz post# 2015

Monday, 10/21/2019 9:02:59 AM

Monday, October 21, 2019 9:02:59 AM

Post# of 2676
Zynerba Pharmaceuticals (NASDAQ:ZYNE) initiated with Buy rating and $18 (124% upside) price target at Needham. Shares up 4% premarket.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News